Stocks in Play

Medicenna Therapeutics Corp.

09:47 AM EST - Medicenna Therapeutics Corp. : Today reported financial results and corporate highlights for the fiscal quarter ended September 30, 2026. Net loss for the quarter was $4.0 million, or $0.04 per share, compared with a net loss of $4.9 million, or $0.06 per share, for the corresponding period in 2025. Medicenna Therapeutics Corp. shares T.MDNA are trading down $0.005 at $0.36.